ออฟไลน์ด้วยแอป Player FM !
Russia tests vaccine science by combining Sputnik and Astrazeneca in new trial
ซีรีส์ที่ถูกเก็บถาวร ("ฟีดที่ไม่ได้ใช้งาน" status)
When? This feed was archived on November 30, 2021 04:09 (). Last successful fetch was on October 28, 2021 05:55 ()
Why? ฟีดที่ไม่ได้ใช้งาน status. เซิร์ฟเวอร์ของเราไม่สามารถดึงฟีดพอดคาสท์ที่ใช้งานได้สักระยะหนึ่ง
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 298458705 series 1612267
In Russia, there's a green light for a new vaccine trial.
The idea is to combine a first dose of the Russian vaccine, Sputnik V, with a second dose of the British AstraZeneca shot.
The country’s registry of approved clinical trials shows the small study was scheduled to start July 26 and will enroll 150 volunteers.
Related: Immunized but banned: EU says not all COVID vaccines equal
Russia still has a lot of jabs left to give. Only about 20% of Russians have been vaccinated with a high prevalence of vaccine hesitancy across Russia.
Judy Twigg, a global public health expert at Virginia Commonwealth University, joins The World's Marco Werman to discuss the science behind this trial.
Related: Vaccine mandates aren't new. But do they work?
Twigg, who specializes in public health in Russia and Eurasia, also shares her views on the current state of the pandemic in Russia.
This interview has been edited and condensed for clarity. AP contributed to this report.
135 ตอน
ซีรีส์ที่ถูกเก็บถาวร ("ฟีดที่ไม่ได้ใช้งาน" status)
When? This feed was archived on November 30, 2021 04:09 (). Last successful fetch was on October 28, 2021 05:55 ()
Why? ฟีดที่ไม่ได้ใช้งาน status. เซิร์ฟเวอร์ของเราไม่สามารถดึงฟีดพอดคาสท์ที่ใช้งานได้สักระยะหนึ่ง
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 298458705 series 1612267
In Russia, there's a green light for a new vaccine trial.
The idea is to combine a first dose of the Russian vaccine, Sputnik V, with a second dose of the British AstraZeneca shot.
The country’s registry of approved clinical trials shows the small study was scheduled to start July 26 and will enroll 150 volunteers.
Related: Immunized but banned: EU says not all COVID vaccines equal
Russia still has a lot of jabs left to give. Only about 20% of Russians have been vaccinated with a high prevalence of vaccine hesitancy across Russia.
Judy Twigg, a global public health expert at Virginia Commonwealth University, joins The World's Marco Werman to discuss the science behind this trial.
Related: Vaccine mandates aren't new. But do they work?
Twigg, who specializes in public health in Russia and Eurasia, also shares her views on the current state of the pandemic in Russia.
This interview has been edited and condensed for clarity. AP contributed to this report.
135 ตอน
ทุกตอน
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ